Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 51 | 47 | −4 |
| Shares | 25.8M | 25.9M | +98.2K (+0.4%) |
| Value | $9.31M | $3.37M | −$5.93M (−63.8%) |
New holders (4)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 754,732 | $98.1K | 0.00% |
| Squarepoint Ops LLC | 148,065 | $19.2K | 0.00% |
| Jane Street Group, LLC | 34,503 | $4.49K | 0.00% |
| XTX Topco Ltd | 33,900 | $4.41K | 0.00% |
Sold out (8)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Courage Capital Management LLC | 331,846 | $119.0K |
| Virtu Financial LLC | 90,298 | $33.0K |
| Charles Schwab Investment Management Inc | 78,387 | $28.2K |
| Global Retirement Partners, LLC | 50,000 | $18.0K |
| Atria Wealth Solutions, Inc. | 39,400 | $14.2K |
| Millennium Management LLC | 17,777 | $6.40K |
| UBS Group AG | 14,307 | $5.15K |
| HRT Financial LP | 10,253 | $3.00K |